StemBioSys

StemBioSys is a Texas-based biomedical company that researches and develops stem cell-derived cardiomyocyte substrates for predicting cardiac safety from drugs.

Business Model:

Revenue: $4.2M

Employees: 11-50

Rankings

Detailed StemBioSys Information

Geographic Data

StemBioSys headquarters map

Address: 3463 Magic Drive

City: San Antonio

State: TX

Zip: 78229

Country: US

Financial Info

Stage:

series b

Raised Last:

$4M

Raised Total:

$14M

Metrics

3,689,296Website Global Rank

3,775Website Monthly Traffic

Twitter Followers

Description

StemBioSys is a Texas-based biomedical company that researches and develops stem cell-derived cardiomyocyte substrates for predicting cardiac safety from drugs.

Contact Phone:
+12108779323

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2018 Series B $4.3M
4/2015 Series A 1 $8M Targeted Technology Fund
Targeted Technology Fund
Targeted Technology Fund
Targeted Technology Fund
4/2016 Equity $4.1M
4/2020 Debt $150k U.S. Small Business Administration.
5/2019 Equity $1.4M
5/2018 Series B $4.1M
9/2021 Series C $6.6M
2/2013 Seed Round $2.4M
Announced Date Name Price
1/2020 Cartox

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research